VARICELLA-ZOSTER VIRUS
Clinical trials for VARICELLA-ZOSTER VIRUS explained in plain language.
Never miss a new study
Get alerted when new VARICELLA-ZOSTER VIRUS trials appear
Sign up with your email to follow new studies for VARICELLA-ZOSTER VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA shot aims to stop painful shingles outbreaks
⭐️ VACCINE ⭐️ OngoingThis study is testing a new, freeze-dried mRNA vaccine designed to prevent shingles (herpes zoster). It will involve about 300 healthy adults aged 40 and up, who will receive two shots about two months apart. The main goals are to see how well the vaccine triggers an immune respo…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 04, 2026 12:22 UTC
-
New mRNA tech takes aim at shingles in early human trial
⭐️ VACCINE ⭐️ OngoingThis is an early-stage study testing a new type of shingles vaccine that uses mRNA technology. It aims to see if the vaccine is safe and triggers a good immune response in 180 healthy adults aged 40 and older. Participants will receive two shots about two months apart, and resear…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 11, 2026 14:52 UTC